155 related articles for article (PubMed ID: 32561500)
21. Biased expression of mutant alleles in cancer-related genes in esophageal squamous cell carcinoma.
Takahashi M; Hosomichi K; Nakaoka H; Sakata H; Uesato N; Murakami K; Kano M; Toyozumi T; Matsumoto Y; Isozaki T; Sekino N; Otsuka R; Inoue I; Matsubara H
Esophagus; 2022 Apr; 19(2):294-302. PubMed ID: 35013873
[TBL] [Abstract][Full Text] [Related]
22. Whole Exome Sequencing Reveals a Novel Damaging Mutation in Human Fibroblast Activation Protein in a Family with Esophageal Squamous Cell Carcinoma.
Golyan FF; Moghaddassian M; Forghanifard MM; Talebi S; Farshchian M; Mahmoudian RA; Abbaszadegan MR
J Gastrointest Cancer; 2020 Mar; 51(1):179-188. PubMed ID: 30957200
[TBL] [Abstract][Full Text] [Related]
23. Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma.
Hong MH; Heo SG; Lee YG; Kim HS; Park KU; Kim HG; Ko YH; Chung IJ; Min YJ; Kim MK; Kim KR; Yoo J; Kim TM; Kim HR; Cho BC
Cancer; 2020 Oct; 126(20):4521-4531. PubMed ID: 32749686
[TBL] [Abstract][Full Text] [Related]
24. Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma.
Park S; Joung JG; Min YW; Nam JY; Ryu D; Oh D; Park WY; Lee SH; Choi Y; Ahn JS; Ahn MJ; Park K; Sun JM
J Immunother Cancer; 2019 May; 7(1):128. PubMed ID: 31097034
[TBL] [Abstract][Full Text] [Related]
25. YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma.
Dai H; Shao YW; Tong X; Wu X; Pang J; Feng A; Yang Z
Cancer Med; 2020 Mar; 9(5):1628-1637. PubMed ID: 31851786
[TBL] [Abstract][Full Text] [Related]
26. Identification of genomic alterations in oesophageal squamous cell cancer.
Song Y; Li L; Ou Y; Gao Z; Li E; Li X; Zhang W; Wang J; Xu L; Zhou Y; Ma X; Liu L; Zhao Z; Huang X; Fan J; Dong L; Chen G; Ma L; Yang J; Chen L; He M; Li M; Zhuang X; Huang K; Qiu K; Yin G; Guo G; Feng Q; Chen P; Wu Z; Wu J; Ma L; Zhao J; Luo L; Fu M; Xu B; Chen B; Li Y; Tong T; Wang M; Liu Z; Lin D; Zhang X; Yang H; Wang J; Zhan Q
Nature; 2014 May; 509(7498):91-5. PubMed ID: 24670651
[TBL] [Abstract][Full Text] [Related]
27. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
[TBL] [Abstract][Full Text] [Related]
28. Multiregion sequencing and subclonal analysis reveal intratumoral heterogeneity in esophageal squamous cell carcinoma.
Gao D; Zhang Z; Yang Q; Li B
J Cancer Res Ther; 2021 Jul; 17(3):756-763. PubMed ID: 34269310
[TBL] [Abstract][Full Text] [Related]
29. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma.
Zhang L; Zhou Y; Cheng C; Cui H; Cheng L; Kong P; Wang J; Li Y; Chen W; Song B; Wang F; Jia Z; Li L; Li Y; Yang B; Liu J; Shi R; Bi Y; Zhang Y; Wang J; Zhao Z; Hu X; Yang J; Li H; Gao Z; Chen G; Huang X; Yang X; Wan S; Chen C; Li B; Tan Y; Chen L; He M; Xie S; Li X; Zhuang X; Wang M; Xia Z; Luo L; Ma J; Dong B; Zhao J; Song Y; Ou Y; Li E; Xu L; Wang J; Xi Y; Li G; Xu E; Liang J; Yang X; Guo J; Chen X; Zhang Y; Li Q; Liu L; Li Y; Zhang X; Yang H; Lin D; Cheng X; Guo Y; Wang J; Zhan Q; Cui Y
Am J Hum Genet; 2015 Apr; 96(4):597-611. PubMed ID: 25839328
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive mutational analysis of background mucosa in patients with Lugol-voiding lesions.
Akizue N; Okimoto K; Arai M; Hirotsu Y; Amemiya K; Oura H; Kaneko T; Tokunaga M; Ishikawa K; Ohta Y; Taida T; Saito K; Maruoka D; Matsumura T; Nakagawa T; Nishimura M; Chiba T; Matsushita K; Mochizuki H; Yokosuka O; Omata M; Kato N
Cancer Med; 2021 Jun; 10(11):3545-3555. PubMed ID: 33934524
[TBL] [Abstract][Full Text] [Related]
31. Absence of NOTCH1 mutation and presence of CDKN2A deletion predict progression of esophageal lesions.
Liu M; Liu Y; Zhou R; Liu Z; Guo C; Xu R; Li F; Liu A; Yang H; Zhang S; Shen L; Duan L; Wu Q; Zhao M; Su H; Liu F; Pan Y; Cai H; He Z; Ke Y
J Pathol; 2022 Sep; 258(1):38-48. PubMed ID: 35612571
[TBL] [Abstract][Full Text] [Related]
32. Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma.
Yan T; Cui H; Zhou Y; Yang B; Kong P; Zhang Y; Liu Y; Wang B; Cheng Y; Li J; Guo S; Xu E; Liu H; Cheng C; Zhang L; Chen L; Zhuang X; Qian Y; Yang J; Ma Y; Li H; Wang F; Liu J; Liu X; Su D; Wang Y; Sun R; Guo S; Li Y; Cheng X; Liu Z; Zhan Q; Cui Y
Nat Commun; 2019 Apr; 10(1):1670. PubMed ID: 30975989
[TBL] [Abstract][Full Text] [Related]
33. Genomic analyses reveal SCN7A is associated with the prognosis of esophageal squamous cell carcinoma.
Yuan P; Rao W; Lin Z; Liu S; Lin X; Wu C; Lin X; Hu Z; Ye W
Esophagus; 2022 Apr; 19(2):303-315. PubMed ID: 34993672
[TBL] [Abstract][Full Text] [Related]
34. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
35. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.
Ueda M; Iguchi T; Masuda T; Nakahara Y; Hirata H; Uchi R; Niida A; Momose K; Sakimura S; Chiba K; Eguchi H; Ito S; Sugimachi K; Yamasaki M; Suzuki Y; Miyano S; Doki Y; Mori M; Mimori K
Oncotarget; 2016 Sep; 7(38):62280-62291. PubMed ID: 27556701
[TBL] [Abstract][Full Text] [Related]
36. TP53 Mutations in Esophageal Squamous Cell Carcinoma.
Zhong L; Li H; Chang W; Ao Y; Wen Z; Chen Y
Front Biosci (Landmark Ed); 2023 Sep; 28(9):219. PubMed ID: 37796679
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of microRNA-136 induces apoptosis and radiosensitivity of esophageal squamous cell carcinoma cells by inhibiting the expression of MUC1.
Huang HZ; Yin YF; Wan WJ; Xia D; Wang R; Shen XM
Exp Mol Pathol; 2019 Oct; 110():104278. PubMed ID: 31247211
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy.
Xu X; Wang Z; Jiang S; Shang Y; Wu Y
Radiat Oncol; 2019 Nov; 14(1):191. PubMed ID: 31684983
[TBL] [Abstract][Full Text] [Related]
39. Whole-Genome Sequencing Reveals Diverse Models of Structural Variations in Esophageal Squamous Cell Carcinoma.
Cheng C; Zhou Y; Li H; Xiong T; Li S; Bi Y; Kong P; Wang F; Cui H; Li Y; Fang X; Yan T; Li Y; Wang J; Yang B; Zhang L; Jia Z; Song B; Hu X; Yang J; Qiu H; Zhang G; Liu J; Xu E; Shi R; Zhang Y; Liu H; He C; Zhao Z; Qian Y; Rong R; Han Z; Zhang Y; Luo W; Wang J; Peng S; Yang X; Li X; Li L; Fang H; Liu X; Ma L; Chen Y; Guo S; Chen X; Xi Y; Li G; Liang J; Yang X; Guo J; Jia J; Li Q; Cheng X; Zhan Q; Cui Y
Am J Hum Genet; 2016 Feb; 98(2):256-74. PubMed ID: 26833333
[TBL] [Abstract][Full Text] [Related]
40. Noninvasive diagnosis and monitoring of mutations by deep sequencing of circulating tumor DNA in esophageal squamous cell carcinoma.
Luo H; Li H; Hu Z; Wu H; Liu C; Li Y; Zhang X; Lin P; Hou Q; Ding G; Wang Y; Li S; Wei D; Qiu F; Li Y; Wu S
Biochem Biophys Res Commun; 2016 Mar; 471(4):596-602. PubMed ID: 26876573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
